Skip to contentCLASSON ROLF A — HILLENBRAND INDUSTRIES INC insider: 364 transactions · InsiderLensCLASSON ROLF A
- Director at HILLENBRAND INDUSTRIES INC · on record since Feb 17, 2006
- Interim President & CEO at HILLENBRAND INDUSTRIES INC · on record since Feb 17, 2006
- Director at ENZON PHARMACEUTICALS INC · on record since Jan 4, 2006
- Director at MASIMO CORP · on record since Dec 21, 2023
- Director at MILLIPORE CORP /MA · on record since Apr 27, 2006
- Director at AUXILIUM PHARMACEUTICALS INC · on record since Jun 8, 2006
- Director at SFBC INTERNATIONAL INC · on record since Oct 27, 2006
- Director at ISTA PHARMACEUTICALS INC · on record since Oct 23, 2006
- Director at Catalent, Inc. · on record since Jul 31, 2014
- Director at PERRIGO CO · on record since May 10, 2017
Insider trading activity of CLASSON ROLF A
- Transactions on record
- 364
- since Oct 2, 2003
- Open-market buys
- 20
- $418.8K
- Open-market sells
- 5
- $10.2M
- Companies traded
- 9
- last filing Dec 18, 2024
Figures computed from official regulatory filings — methodology.
Companies where CLASSON ROLF A has traded
- Catalent, Inc.12 tx · Dec 18, 2024
- MASIMO CORP1 tx · Dec 21, 2023
- PERRIGO CO19 tx · $2.1M · Dec 3, 2021
- HILLENBRAND INDUSTRIES INC151 tx · $5.2M · Mar 16, 2017
- AUXILIUM PHARMACEUTICALS INC76 tx · $16.7M · Jan 30, 2015
- ENZON PHARMACEUTICALS INC49 tx · $375.7K · Jan 5, 2011
- MILLIPORE CORP /MA48 tx · $1.6M · Jul 16, 2010
- SFBC INTERNATIONAL INC3 tx · $332.5K · Mar 24, 2009
- ISTA PHARMACEUTICALS INC5 tx · $323.8K · Mar 13, 2007
Track record of CLASSON ROLF A
Statistical track record
Free- Open-market buys
- 20
- Last buy
- Dec 2, 2021
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of CLASSON ROLF A
Co-insiders of CLASSON ROLF A
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
ADAMS MICHAEL PSFBC INTERNATIONAL INC
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Dec 18, 2024 | Other | -47,984 | — | — | SEC |
| Nov 1, 2024 | Award | 4,663 | 0.00 USD | $0 | SEC |
| Dec 21, 2023 | AwardD | 1,726 | 0.00 USD | $0 | SEC |
| Oct 31, 2023 | Award | 6,993 | 0.00 USD | $0 | SEC |
| Oct 31, 2022 | Award | 4,149 | 0.00 USD | $0 | SEC |
| Dec 3, 2021 | Buy | 2,800 | 35.67 USD | $99.9K | SEC |
| Nov 1, 2021 | Award | 1,402 | 0.00 USD | $0 | SEC |
| May 19, 2021 | AwardD | 8,249 | — | — | SEC |
| May 11, 2021 | Other | -3,483 | 42.96 USD | $149.6K | SEC |
| May 11, 2021 | ExerciseD | -7,255 | — | — | SEC |
| May 11, 2021 | Exercise | 7,255 | 42.96 USD | $311.7K | SEC |
| Nov 10, 2020 | Buy | 2,137 | 46.75 USD | $99.9K | SEC |
| Nov 2, 2020 | Award | 2,125 | 0.00 USD | $0 | SEC |
| Aug 28, 2020 | Award | 661 | 0.00 USD | $0 | SEC |
| May 19, 2020 | Exercise | 7,568 | 52.76 USD | $399.3K | SEC |
| May 19, 2020 | ExerciseD | -7,568 | — | — | SEC |
| May 19, 2020 | Other | -3,633 | 52.76 USD | $191.7K | SEC |
| May 11, 2020 | AwardD | 7,255 | — | — | SEC |
| Aug 26, 2019 | Award | 3,167 | 0.00 USD | $0 | SEC |
| May 17, 2019 | Other | -2,383 | 49.55 USD | $118.1K | SEC |
| May 17, 2019 | Exercise | 4,964 | 49.55 USD | $246K | SEC |
| May 17, 2019 | AwardD | 7,568 | — | — | SEC |
| May 17, 2019 | ExerciseD | -4,964 | — | — | SEC |
| Aug 24, 2018 | Award | 4,183 | 0.00 USD | $0 | SEC |
| Jun 8, 2018 | Other | -2,048 | 73.22 USD | $150K | SEC |